|
Real-time Estimate
Cboe BZX
19:21:16 29/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 82.76 USD | -1.02% |
|
+18.25% | +405.70% |
| 10-23 | Stephens Downgrades 10x Genomics to Equal Weight From Overweight, $65 Price Target | MT |
| 10-09 | BofA Securities Adjusts 10x Genomics Price Target to $80 From $50 | MT |
| Market Cap | 10.89B 9.77B 9.04B 8.18B 15.29B 1,038B 15.48B 108B 43.04B 543B 40.88B 40.02B 1,724B | P/E 2026 * |
-114x | P/E 2027 * | -119x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45B 9.38B 8.67B 7.85B 14.67B 995B 14.84B 104B 41.28B 521B 39.22B 38.39B 1,653B | EV / Sales 2026 * |
16.8x | EV / Sales 2027 * | 15.2x |
| Free-Float |
90.93% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| TXG | Delayed | |
CBOE
| TXG | Real-time | |
|
Tradegate
| 1KJ | Real-time | |
|
Xetra
| 1KJ | Delayed | |
|
London S.E.
| 0A88 | Delayed | |
|
Boerse Muenchen
| 1KJ | Real-time | |
|
Mexican S.E.
| TXG * | End-of-day quote | |
|
Deutsche Boerse AG
| 1KJ | Delayed | |
|
Börse Stuttgart
| 1KJ | Delayed |
Last Transcript: 10x Genomics, Inc.
| 1 day | -1.00% | ||
| 1 week | +18.25% | ||
| Current month | -8.72% | ||
| 1 month | -8.40% | ||
| 3 months | +78.07% | ||
| 6 months | +308.32% | ||
| Current year | +405.70% |
| 1 week | 67.52 |  | 87.82 |
| 1 month | 67.25 | | 102.81 |
| Current year | 15.9 | | 102.81 |
| 1 year | 12.34 | | 102.81 |
| 3 years | 6.78 | | 102.81 |
| 5 years | 6.78 | | 187.85 |
| 10 years | 6.78 | | 208.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Serge Saxonov
CEO | Chief Executive Officer | 49 | 02/07/2012 |
Ben Hindson
PSD | President | 51 | 01/10/2012 |
Adam Taich
DFI | Director of Finance/CFO | 51 | 12/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Ben Hindson
BRD | Director/Board Member | 51 | 02/07/2012 |
Serge Saxonov
BRD | Director/Board Member | 49 | 02/07/2012 |
John Stuelpnagel
CHM | Chairman | 68 | 01/08/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/22/26 A | Sell | Director | -5,723 | 0.0048% | ||
| 9/22/26 A | Sell | Founder | -25,000 | 0.0208% | ||
| 9/9/26 A | Sell | Chief Financial Officer | -46,388 | 0.0386% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.02% | +18.25% | +539.38% | +130.71% | 10.89B | |
| +1.45% | +1.29% | -16.55% | +11.65% | 178B | |
| +2.69% | +1.43% | -15.72% | +18.62% | 117B | |
| +2.12% | +0.06% | +5.36% | +38.13% | 116B | |
| +0.59% | +0.90% | -43.84% | +6.22% | 91.03B | |
| +1.13% | -3.24% | -1.69% | +76.65% | 61.89B | |
| -0.32% | -0.66% | +10.51% | +81.65% | 55.85B | |
| +0.64% | -2.05% | +8.15% | -21.81% | 53.16B | |
| +1.54% | +0.86% | -8.93% | +44.21% | 44.35B | |
| +1.91% | +1.49% | -1.21% | -7.06% | 33.59B | |
| Average | +1.08% | +1.91% | +47.55% | +37.90% | 76.1B | |
| Weighted average by Cap. | +1.42% | +1.39% | -2.35% | +26.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 621M 557M 515M 466M 871M 59.1B 882M 6.15B 2.45B 30.93B 2.33B 2.28B 98.19B | 683M 613M 567M 513M 959M 65.08B 971M 6.78B 2.7B 34.06B 2.56B 2.51B 108B |
| Net income | -95.86M -86.01M -79.52M -72.01M -135M -9.13B -136M -951M -379M -4.78B -360M -352M -15.17B | -90.23M -80.95M -74.84M -67.78M -127M -8.59B -128M -895M -356M -4.5B -339M -331M -14.28B |
| Net Debt | -445M -399M -369M -334M -624M -42.34B -632M -4.41B -1.76B -22.16B -1.67B -1.63B -70.34B | -527M -473M -437M -396M -739M -50.17B -748M -5.22B -2.08B -26.25B -1.98B -1.93B -83.34B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/10/26 | $82.56 | -1.27% | 757,475 |
| 28/10/26 | $83.62 | +7.18% | 5,047,435 |
| 27/10/26 | $78.02 | +6.94% | 2,129,136 |
| 26/10/26 | $72.96 | +1.97% | 1,413,121 |
| 23/10/26 | $71.55 | +2.58% | 2,227,699 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TXG Stock
Select your edition
All financial news and data tailored to specific country editions
